Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Dr. Fan will be responsible for CARsgen global regulatory strategy, leading the U.S. and China regulatory affairs team
January 6, 2020
By: Kristin Brooks
Managing Editor, Contract Pharma
CARsgen Therapeutics, a clinical-stage company developing Chimeric Antigen Receptor T cell therapies for cancer, has appointed Yong Fan, MD, as senior vice president, Global Regulatory Affairs. Dr. Fan will be responsible for CARsgen global regulatory strategy, leading the U.S. and China regulatory affairs team and working with clinical, medical and process development teams to advance CARsgen’s strategic objectives for immunotherapies. Dr. Fan previously served as A2Z Reg Solutions senior consultant and owner, member of ISCT Legal and Regulatory Affairs North America Committee, and senior reviewer in the FDA Office of Tissues and Advanced Therapies (OTAT/Previous OCTGT), Center for Biologics Evaluation and Research (CBER), responsible for review, evaluation and inspection for cellular and gene therapies’ pre-IND, IND and BLA. Prior to the FDA, she served in several roles as staff scientist at the Cell Processing Section of National Institute of Health, Laboratory Supervisor of Cellular Activities in the Gene Transfer Core Facility at the Memorial Sloan-Kettering Cancer Center, Cell Processing Lab Supervisor for New York Presbyterian Hospital-University Hospital of Columbia and Weill Cornell. “Dr. Fan’s insights and rich experiences of regulatory strategy consulting, FDA review and regulatory inspection, cell and gene therapy research & development, and related policy implementation is a precious asset as CARsgen is developing its global strategy,” said Dr. Zonghai Li, founder and chief executive officer of CARsgen. “In the near future, CARsgen aims to submit several INDs, BLAs to U.S. FDA, China NMPA and other regulatory agencies for our advanced CAR-T cell programs. We are delighted to have Dr. Fan joined, together with more and more global top talents to deliver our commitment to cancer patients.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !